LabCorp Buying Orchid Cellmark for $85.4M

LabCorp will purchase 30.5 million outstanding shares of Orchid Cellmark, including options, at $2.80 per share.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories